Advances in immunotherapy for colorectal malignancies
Publication
, Journal Article
McKinney, M; Morse, MA
Published in: Current Colorectal Cancer Reports
October 1, 2008
In the past decade, numerous advances have been made in resection, adjuvant treatment, and targeted therapies for colorectal malignancies; however, survival in the setting of metastatic disease treated with the most recent guideline-based therapy is only about 13 months. There has been mounting evidence that immune pathways are important in the development, progression, and regression of colorectal malignancies. This article explores the past attempts to harness immunotherapy against colorectal cancer and considers the future of colorectal cancer immunotherapeutics. Copyright © 2008 by Current Medicine Group LLC.
Duke Scholars
Published In
Current Colorectal Cancer Reports
DOI
EISSN
1556-3804
ISSN
1556-3790
Publication Date
October 1, 2008
Volume
4
Issue
4
Start / End Page
177 / 183
Citation
APA
Chicago
ICMJE
MLA
NLM
McKinney, M., & Morse, M. A. (2008). Advances in immunotherapy for colorectal malignancies. Current Colorectal Cancer Reports, 4(4), 177–183. https://doi.org/10.1007/s11888-008-0029-7
McKinney, M., and M. A. Morse. “Advances in immunotherapy for colorectal malignancies.” Current Colorectal Cancer Reports 4, no. 4 (October 1, 2008): 177–83. https://doi.org/10.1007/s11888-008-0029-7.
McKinney M, Morse MA. Advances in immunotherapy for colorectal malignancies. Current Colorectal Cancer Reports. 2008 Oct 1;4(4):177–83.
McKinney, M., and M. A. Morse. “Advances in immunotherapy for colorectal malignancies.” Current Colorectal Cancer Reports, vol. 4, no. 4, Oct. 2008, pp. 177–83. Scopus, doi:10.1007/s11888-008-0029-7.
McKinney M, Morse MA. Advances in immunotherapy for colorectal malignancies. Current Colorectal Cancer Reports. 2008 Oct 1;4(4):177–183.
Published In
Current Colorectal Cancer Reports
DOI
EISSN
1556-3804
ISSN
1556-3790
Publication Date
October 1, 2008
Volume
4
Issue
4
Start / End Page
177 / 183